Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Item No. 18602

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSDimethyl DL-glutamate is a cell-permeant glutamic acid derivative that enhances insulin release in response to glucose in isolated islets and in animal models of diabetes.1,2 It also potentiates the insulinotropic potential of glyburide (Item No. 15009) and glucagon-like peptide 1.1,2 Dimethyl DL-glutamate is used as a cell-permeable form of glutamate in studies of glutamate action in β-cells.3,4 However, it can be cytotoxic to myeloid cells and act as an antagonist of glutamate-mediated neurosignaling.5,6
WARNING This product is not for human or veterinary use.
1. Insulinotropic action of glutamic acid dimethyl ester. Am. J. Physiol. 267(4 Pt 1), E573-E584 (1994).
2. Potentiation and prolongation of the insulinotropic action of glucagon-
3. Mitochondrial glutamate carrier GC1 as a newly identified player in the control of glucose-
4. Delineation of glutamate pathways and secretory responses in pancreatic islets with β-
5. Spectrum of toxicities of amino acid methyl esters for myeloid cells is determined by distinct metabolic pathways. Blood 79(4), 964-971 (1992).
6. Glutamate antagonists in rat hippocampus. Br. J. Pharmacol. 58(3), 341-345 (1976).